Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CTCs and Novel Target Bio-marker Analysis for Prediction and Monitoring of Metastasis/Recurrence in Post-surgery Colorectal Cancer Patients Using MiSelect R Rare Cell System

NCT03013868 is registered in ClinicalTrials.gov with MiCareo Taiwan Co., Ltd. as lead sponsor.

NCT NCT03013868
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03013868 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CTCs and Novel Target Bio-marker Analysis for Prediction and Monitoring of Metastasis/Recurrence in Post-surgery Colorectal Cancer Patients Using MiSelect R Rare Cell System
Lead sponsor
MiCareo Taiwan Co., Ltd.
Phase
Observational
Overall status
Unknown status
Start date
October 31, 2016
Completion date
February 28, 2021
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

circulating tumor cells, ctc